Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications

Circular RNAs (circRNAs) are class of non-coding RNA, which are characterized by a covalently closed loop structure. Functionally they can act on cellular physiology, notably by sponging microRNAs (miR), regulating gene expression or interacting with binding protein. To date, circRNAs might represen...

Full description

Bibliographic Details
Main Authors: Melissa Yepmo, Jean-Baptiste Potier, Michel Pinget, Anastasia Grabarz, Karim Bouzakri, Aurore Dumond Bourie
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1035159/full
_version_ 1797984559569043456
author Melissa Yepmo
Jean-Baptiste Potier
Jean-Baptiste Potier
Michel Pinget
Anastasia Grabarz
Karim Bouzakri
Karim Bouzakri
Aurore Dumond Bourie
author_facet Melissa Yepmo
Jean-Baptiste Potier
Jean-Baptiste Potier
Michel Pinget
Anastasia Grabarz
Karim Bouzakri
Karim Bouzakri
Aurore Dumond Bourie
author_sort Melissa Yepmo
collection DOAJ
description Circular RNAs (circRNAs) are class of non-coding RNA, which are characterized by a covalently closed loop structure. Functionally they can act on cellular physiology, notably by sponging microRNAs (miR), regulating gene expression or interacting with binding protein. To date, circRNAs might represent an interesting, underexploited avenue for new target discovery for therapeutic applications, especially in the liver. The first characteristic of non-alcoholic fatty liver disease (NAFLD) is hepatic cholesterol accumulation, followed by its advanced form of the affection, nonalcoholic steatohepatitis (NASH), due to the occurrence of lobular inflammation, irreversible fibrosis, and in some cases hepatocellular carcinoma (HCC). Therefore, studies have investigated the importance of the dysregulation of circRNAs in the onset of metabolic disorders. In this review, we summarize the potential role of circRNAs in the development of metabolic diseases associated with the liver such as NAFLD or NASH, and their potential to become therapeutic strategies for these pathologies.
first_indexed 2024-04-11T07:03:34Z
format Article
id doaj.art-86bc648213ab49b3aa6de5bd3a304987
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T07:03:34Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-86bc648213ab49b3aa6de5bd3a3049872022-12-22T04:38:33ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-11-011310.3389/fendo.2022.10351591035159Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complicationsMelissa Yepmo0Jean-Baptiste Potier1Jean-Baptiste Potier2Michel Pinget3Anastasia Grabarz4Karim Bouzakri5Karim Bouzakri6Aurore Dumond Bourie7Centre européen d’étude du Diabète, Unité Mixte de Recherche de l’Université de Strasbourg « Diabète et Thérapeutique », Strasbourg, FranceCentre européen d’étude du Diabète, Unité Mixte de Recherche de l’Université de Strasbourg « Diabète et Thérapeutique », Strasbourg, FranceILONOV, Strasbourg, FranceCentre européen d’étude du Diabète, Unité Mixte de Recherche de l’Université de Strasbourg « Diabète et Thérapeutique », Strasbourg, FranceILONOV, Strasbourg, FranceCentre européen d’étude du Diabète, Unité Mixte de Recherche de l’Université de Strasbourg « Diabète et Thérapeutique », Strasbourg, FranceILONOV, Strasbourg, FranceCentre européen d’étude du Diabète, Unité Mixte de Recherche de l’Université de Strasbourg « Diabète et Thérapeutique », Strasbourg, FranceCircular RNAs (circRNAs) are class of non-coding RNA, which are characterized by a covalently closed loop structure. Functionally they can act on cellular physiology, notably by sponging microRNAs (miR), regulating gene expression or interacting with binding protein. To date, circRNAs might represent an interesting, underexploited avenue for new target discovery for therapeutic applications, especially in the liver. The first characteristic of non-alcoholic fatty liver disease (NAFLD) is hepatic cholesterol accumulation, followed by its advanced form of the affection, nonalcoholic steatohepatitis (NASH), due to the occurrence of lobular inflammation, irreversible fibrosis, and in some cases hepatocellular carcinoma (HCC). Therefore, studies have investigated the importance of the dysregulation of circRNAs in the onset of metabolic disorders. In this review, we summarize the potential role of circRNAs in the development of metabolic diseases associated with the liver such as NAFLD or NASH, and their potential to become therapeutic strategies for these pathologies.https://www.frontiersin.org/articles/10.3389/fendo.2022.1035159/fullNASHNAFLDcircRNAlivercrosstalkhepatocellular carcinoma
spellingShingle Melissa Yepmo
Jean-Baptiste Potier
Jean-Baptiste Potier
Michel Pinget
Anastasia Grabarz
Karim Bouzakri
Karim Bouzakri
Aurore Dumond Bourie
Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
Frontiers in Endocrinology
NASH
NAFLD
circRNA
liver
crosstalk
hepatocellular carcinoma
title Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
title_full Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
title_fullStr Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
title_full_unstemmed Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
title_short Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
title_sort discussing the role of circular rna in the pathogenesis of non alcoholic fatty liver disease and its complications
topic NASH
NAFLD
circRNA
liver
crosstalk
hepatocellular carcinoma
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1035159/full
work_keys_str_mv AT melissayepmo discussingtheroleofcircularrnainthepathogenesisofnonalcoholicfattyliverdiseaseanditscomplications
AT jeanbaptistepotier discussingtheroleofcircularrnainthepathogenesisofnonalcoholicfattyliverdiseaseanditscomplications
AT jeanbaptistepotier discussingtheroleofcircularrnainthepathogenesisofnonalcoholicfattyliverdiseaseanditscomplications
AT michelpinget discussingtheroleofcircularrnainthepathogenesisofnonalcoholicfattyliverdiseaseanditscomplications
AT anastasiagrabarz discussingtheroleofcircularrnainthepathogenesisofnonalcoholicfattyliverdiseaseanditscomplications
AT karimbouzakri discussingtheroleofcircularrnainthepathogenesisofnonalcoholicfattyliverdiseaseanditscomplications
AT karimbouzakri discussingtheroleofcircularrnainthepathogenesisofnonalcoholicfattyliverdiseaseanditscomplications
AT auroredumondbourie discussingtheroleofcircularrnainthepathogenesisofnonalcoholicfattyliverdiseaseanditscomplications